Peiru R Wang (Peiru Wang)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Juvenile Idiopathic Arthritis

Top Venues

The Australasian journal of dermatology

Photodermatology, photoimmunology & photomedicine

Journal of translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yutong Yang, Jia Yan, Jin Yang, Peiru R Wang, Ye-Qiang Liu, Xiuli L Wang
Janus kinase inhibitor Abrocitinib as an Off-Label treatment for tattoo granuloma with uveitis (TAGU). The Australasian journal of dermatology 65 (3) (2024)
Yutong Yang, Jia Yan, Jin Yang, Peiru R Wang, Ye-Qiang Liu, Xiuli L Wang
Janus kinase inhibitor Abrocitinib as an Off-Label treatment for tattoo granuloma with uveitis (TAGU). The Australasian journal of dermatology (2024)
Yutong Yang, Jia Yan, Jin Yang, Peiru R Wang, Ye-Qiang Liu, Xiuli L Wang
Janus kinase inhibitor Abrocitinib as an Off-Label treatment for tattoo granuloma with uveitis (TAGU). The Australasian journal of dermatology 65 (3) (2024)
Jiandan Li, Xiaojing Liu, Qian Du, Xiuli Wang, Peiru R Wang
Porokeratotic lichen planus of the lower extremities. The Australasian journal of dermatology (2023)
Yuling L Yang, Xiuli L Wang, Peiru R Wang
Signaling mechanisms underlying lymphatic vessel dysfunction in skin aging and possible anti-aging strategies. Biogerontology (2023)
Yuling L Yang, Chu Zhou, Qi Chen, Shuzhan Z Shen, Jiandan D Li, Xiuli L Wang, Peiru R Wang
YAP1/Piezo1 involve in the dynamic changes of lymphatic vessels in UVR-induced photoaging progress to squamous cell carcinoma. Journal of translational medicine 21 (1) (2023)
Jiandan Li, Yunfeng Zhang, Guolong Zhang, Linglin Zhang, Zhongxia Zhou, Peiru R Wang, Xiuli Wang
Modified painless photodynamic therapy for facial multiple actinic keratosis in China: A prospective split-face control study. Lasers in surgery and medicine (2023)
Jiahua Li, Jiandan Li, Linglin Zhang, Xiaojing Liu, Yajing Cao, Peiru R Wang, Xiuli Wang
Comparison of red light and blue light therapies for mild-to-moderate acne vulgaris: A randomized controlled clinical study. Photodermatology, photoimmunology & photomedicine 38 (5) (2022)